Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 7/2008

01-07-2008 | Original Article

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

Authors: Jennifer K. Mulligan, Deanne M. R. Lathers, M. Rita I. Young

Published in: Cancer Immunology, Immunotherapy | Issue 7/2008

Login to get access

Abstract

Introduction

Patients and mice with solid tumors, such as Lewis lung carcinoma (LLC), have defects in functions of immune effector cells. Endothelial cells, a component of the tumor vasculature, are potential regulators of immune cell functions. Therefore, these studies examined the impact of exposure to LLC tumor on the ability of endothelial cells to modulate immune cell functions.

Materials and methods

Endothelial cells were pre-treated with LLC tumor-conditioned medium (EndoT-sup) for 24 h. Control endothelial cells that were exposed to medium (EndoMedia) or epithelial cell-conditioned medium (EndoEpi-sup). After the initial 24 h incubation, endothelial cells were washed and fresh media was added. Cells were allowed to incubate for an additional 24 h. Supernatants from EndoMedia, EndoEpi-sup or EndoT-sup were collected and assayed for immune modulatory products and for immune modulatory activity.

Results

Supernatant from EndoT-sup contained increased levels of PGE2, IL-6 and VEGF as compared to EndoMedia and EndoEpi-sup controls. NK cell activity, as measured by TNF-α and IFN-γ secretion, was increased following exposure to media conditioned by EndoMedia and EndoEpi-sup. Exposure of NK cells to supernatants of EndoT-sup, also increases TNF-α and IFN-γ secretion, but to a lesser extent than by EndoMedia and EndoEpi-sup. Examination of macrophage functions demonstrated that supernatant from EndoT-sup decreased microbead phagocytosis and increased production of the immune suppressive mediators, IL-10 and PGE2. Lastly, T-cell responses to stimulation with anti-CD3 in the presence of supernatants from EndoT-sup were examined. IFN-γ production by CD8+ T-cells was reduced after exposure to EndoT-sup-conditioned medium, as compared to cells treatments with medium or control conditioned medium. Production of IFN-γ by CD4+ T-cells exposed to EndoT-sup was not altered.

Conclusions

Taken together, these studies demonstrate that tumors skew endothelial cells to disrupt NK cell, T-cell and macrophages functions, and represents a novel mechanism of tumor-induced immune suppression.
Literature
1.
go back to reference Barker LP (2006) Mycobacterium leprae interactions with the host cell: recent advances. Indian J Med Res 123:748–759PubMed Barker LP (2006) Mycobacterium leprae interactions with the host cell: recent advances. Indian J Med Res 123:748–759PubMed
2.
go back to reference Berg M, Wingender G, Djandji D, Hegenbarth S, Momburg F, Hammerling G, Limmer A, Knolle P (2006) Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance. Eur J Immunol 36:2960–2970PubMedCrossRef Berg M, Wingender G, Djandji D, Hegenbarth S, Momburg F, Hammerling G, Limmer A, Knolle P (2006) Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance. Eur J Immunol 36:2960–2970PubMedCrossRef
3.
go back to reference Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH (1997) Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol 159:3247–3256PubMed Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH (1997) Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol 159:3247–3256PubMed
4.
go back to reference Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S et al (1997) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med 10:942–949 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S et al (1997) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med 10:942–949
5.
go back to reference Danese S, Dejana E, Fiocchi C (2007) Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178:6017–6022PubMed Danese S, Dejana E, Fiocchi C (2007) Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178:6017–6022PubMed
6.
go back to reference Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9):531–536PubMedCrossRef Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9):531–536PubMedCrossRef
7.
go back to reference Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64:275–290PubMed Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64:275–290PubMed
8.
go back to reference Finke J, Ferrone S, Frey A, Mufson A, Ochoa A (1999) Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 20:158–160PubMedCrossRef Finke J, Ferrone S, Frey A, Mufson A, Ochoa A (1999) Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 20:158–160PubMedCrossRef
9.
go back to reference Gallia GL, Tamargo RJ (2006) Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:750–758PubMedCrossRef Gallia GL, Tamargo RJ (2006) Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:750–758PubMedCrossRef
10.
go back to reference Leek RD, Harris AL (2002) Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7:177–189PubMedCrossRef Leek RD, Harris AL (2002) Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7:177–189PubMedCrossRef
11.
go back to reference Lizee G, Radvanyi LG, Overwijk WW, Hwu P (2006) Improving antitumor immune responses by circumventing immunoregulatory. Cells Mech 12:4794–4803 Lizee G, Radvanyi LG, Overwijk WW, Hwu P (2006) Improving antitumor immune responses by circumventing immunoregulatory. Cells Mech 12:4794–4803
12.
go back to reference Katz SC, Pillarisetty VG, Bleier JI, Shah AB, DeMatteo RP (2004) Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 173:230–235PubMed Katz SC, Pillarisetty VG, Bleier JI, Shah AB, DeMatteo RP (2004) Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 173:230–235PubMed
13.
go back to reference Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P (2006) Human microvascular endothelial cell activation by IL-1 and TNF-α stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional. Osteoclasts 21:193–206 Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P (2006) Human microvascular endothelial cell activation by IL-1 and TNF-α stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional. Osteoclasts 21:193–206
14.
go back to reference Konur A, Kreutz M, Knuchel R, Krause SW, Andreesen R (1996) Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int J Cancer 66:645–652PubMedCrossRef Konur A, Kreutz M, Knuchel R, Krause SW, Andreesen R (1996) Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int J Cancer 66:645–652PubMedCrossRef
15.
go back to reference Krupnick AS, Gelman AE, Barchet W, Richardson S, Kreisel FH, Turka LA, Colonna M, Patterson GA, Kreisel D (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4 + 25+Foxp3+ regulatory T cells. J Immunol 175:6265–6270PubMed Krupnick AS, Gelman AE, Barchet W, Richardson S, Kreisel FH, Turka LA, Colonna M, Patterson GA, Kreisel D (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4 + 25+Foxp3+ regulatory T cells. J Immunol 175:6265–6270PubMed
16.
go back to reference Lefkowitz DL, Roberts E, Grattendick K, Schwab C, Stuart R, Lincoln J, Allen RC, Moguilevsky N, Bollen A, Lefkowitz SS (2000) The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell Immunol 202(1):23–30PubMedCrossRef Lefkowitz DL, Roberts E, Grattendick K, Schwab C, Stuart R, Lincoln J, Allen RC, Moguilevsky N, Bollen A, Lefkowitz SS (2000) The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell Immunol 202(1):23–30PubMedCrossRef
17.
go back to reference Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF (1994) Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152:5077–5083PubMed Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF (1994) Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152:5077–5083PubMed
18.
go back to reference Lienenluke B, Germann T, Kroczek RA, Hecker M (2000) CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 30:2864–2870PubMedCrossRef Lienenluke B, Germann T, Kroczek RA, Hecker M (2000) CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 30:2864–2870PubMedCrossRef
19.
go back to reference Ma W, Pober JS (1998) Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 161:2158–2167PubMed Ma W, Pober JS (1998) Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 161:2158–2167PubMed
20.
go back to reference Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25(3):315–322PubMedCrossRef Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25(3):315–322PubMedCrossRef
21.
go back to reference Mitsuhashi M, Liu J, Cao S, Shi X, Ma X (2004) Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leulock Biol 76(2):322–332CrossRef Mitsuhashi M, Liu J, Cao S, Shi X, Ma X (2004) Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leulock Biol 76(2):322–332CrossRef
22.
go back to reference Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 178:5552–5562PubMed Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 178:5552–5562PubMed
23.
go back to reference Ohira H, Abe K, Yokokawa J, Takiguchi J, Rai T, Shishido S, Sato Y (2003) Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 49:1–13PubMed Ohira H, Abe K, Yokokawa J, Takiguchi J, Rai T, Shishido S, Sato Y (2003) Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 49:1–13PubMed
24.
go back to reference Ohm JE, Gabrilovich DI, Sempowski GD, Sempowski E, Parman KS, Nadaf S, Carbone DP (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101:4878–4886PubMedCrossRef Ohm JE, Gabrilovich DI, Sempowski GD, Sempowski E, Parman KS, Nadaf S, Carbone DP (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101:4878–4886PubMedCrossRef
25.
go back to reference Papamichail M, Perez S, Gritzapis A, Baxevanis C (2004) Natural killer lymphocytes: biology, development and function. Cancer Immunol Immunother 53:176–186PubMedCrossRef Papamichail M, Perez S, Gritzapis A, Baxevanis C (2004) Natural killer lymphocytes: biology, development and function. Cancer Immunol Immunother 53:176–186PubMedCrossRef
26.
go back to reference Pirtskhalaishvili G, Nelson JB (2000) Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44:77–87PubMedCrossRef Pirtskhalaishvili G, Nelson JB (2000) Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44:77–87PubMedCrossRef
27.
go back to reference Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P (2004) Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol 11(3):328–339PubMedCrossRef Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P (2004) Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol 11(3):328–339PubMedCrossRef
28.
go back to reference Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ (2003) Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33:3117–126PubMedCrossRef Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ (2003) Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33:3117–126PubMedCrossRef
29.
go back to reference Young MR (2004) Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:375–382PubMedCrossRef Young MR (2004) Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:375–382PubMedCrossRef
30.
go back to reference Young MR, Wright MA, Matthews JP, Malik I, Prechel M (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol 156:1916–1922PubMed Young MR, Wright MA, Matthews JP, Malik I, Prechel M (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol 156:1916–1922PubMed
Metadata
Title
Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions
Authors
Jennifer K. Mulligan
Deanne M. R. Lathers
M. Rita I. Young
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 7/2008
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-007-0425-x

Other articles of this Issue 7/2008

Cancer Immunology, Immunotherapy 7/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine